Insulet Corporation (PODD)

Insulet Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	1,781	1,697	1,305	1,099	904.4	738.2
Revenue Growth (YoY)	30.17%	30.02%	18.79%	21.49%	22.51%	30.93%
Cost of Revenue	554.5	537.2	499.7	346.7	322.1	257.9
Gross Profit	1,226	1,160	805.6	752.1	582.3	480.3
Selling, General & Admin	771.9	734.9	587.8	466	384	298
Research & Development	205.1	205	180.2	160.1	146.8	132.3
Operating Expenses	977	939.9	768	626.1	530.8	430.3
Operating Income	249.2	220	37.6	126	51.5	50
Interest Expense / Income	30.2	36.2	36	61.7	45.1	27.7
Other Expense / Income	-25.9	-30.8	-8.2	43.8	-3.3	7.8
Pretax Income	244.9	214.6	9.8	20.5	9.7	14.5
Income Tax	10.9	8.3	5.2	3.7	2.9	2.9
Net Income	234	206.3	4.6	16.8	6.8	11.6
Net Income Growth	38900.00%	4384.78%	-72.62%	147.06%	-41.38%	251.52%
Shares Outstanding (Basic)	70	70	69	68	65	61
Shares Outstanding (Diluted)	74	74	70	69	66	62
Shares Change	5.20%	5.33%	1.94%	3.99%	5.85%	2.12%
EPS (Basic)	3.35	2.96	0.07	0.25	0.11	0.19
EPS (Diluted)	3.33	2.94	0.07	0.24	0.10	0.19
EPS Growth	33200.00%	4100.00%	-70.83%	140.00%	-47.37%	280.00%
Free Cash Flow	111.6	36.5	-38.3	-190.8	-82.5	-65.3
Free Cash Flow Per Share	1.59	0.52	-0.55	-2.82	-1.27	-1.08
Gross Margin	68.86%	68.35%	61.72%	68.45%	64.39%	65.06%
Operating Margin	13.99%	12.96%	2.88%	11.47%	5.69%	6.77%
Profit Margin	13.14%	12.16%	0.35%	1.53%	0.75%	1.57%
Free Cash Flow Margin	6.27%	2.15%	-2.93%	-17.36%	-9.12%	-8.85%
Effective Tax Rate	4.45%	3.87%	53.06%	18.05%	29.90%	20.00%
EBITDA	349.5	323.6	109	139.6	110.2	70.1
EBITDA Margin	19.63%	19.07%	8.35%	12.70%	12.18%	9.50%
Depreciation & Amortization	74.4	72.8	63.2	57.4	55.4	27.9
EBIT	275.1	250.8	45.8	82.2	54.8	42.2
EBIT Margin	15.45%	14.78%	3.51%	7.48%	6.06%	5.72%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).